Document is current
Any future updates will be listed below
-
Authors
Scott, Mary T. https://orcid.org/0000-0002-7177-6960
Liu, Wei
Mitchell, Rebecca
Clarke, Cassie J. https://orcid.org/0000-0003-2232-1609
Kinstrie, Ross
Warren, Felix https://orcid.org/0000-0002-5727-020X
Almasoudi, Hassan https://orcid.org/0000-0002-6722-6667
Stevens, Thomas
Dunn, Karen https://orcid.org/0000-0002-6532-970X
Pritchard, John https://orcid.org/0000-0002-1812-6985
Drotar, Mark E.
Michie, Alison M. https://orcid.org/0000-0002-5404-475X
Jørgensen, Heather G. https://orcid.org/0000-0003-4663-4191
Higgins, Brian
Copland, Mhairi https://orcid.org/0000-0002-7655-016X
Vetrie, David https://orcid.org/0000-0003-2075-4662
- License Information
-
More Information
Article History
Received: 24 October 2022
Accepted: 4 January 2024
First Online: 22 January 2024
Competing interests
: M.C. has received research funding from Cyclacel and Incyte, honoraria from Astellas, Novartis, Incyte, Pfizer, and Jazz Pharmaceuticals, and is/has been an advisory board member for Novartis, Incyte, Jazz Pharmaceuticals and Pfizer. B.H. is an employee of Genentech Inc (Roche Group). The remaining authors have declared that no conflict of interest exists.
